{ "docId": "019dd923-622c-750b-8b9a-2a2468219173", "docSlug": "ce565b841c40", "documentTitle": "Nevro Corp. (NVRO)", "authorId": "58_Scorpion_Capital", "authorName": "Kir Kahlon", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2021-01-07 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 92, "pageCount": 239, "prevPage": 91, "nextPage": 93, "slideType": "expose_contradiction", "function": "expose_contradiction", "density": "overcrowded", "nDataPoints": 1, "notes": "Uses highlighted quotes to emphasize negative feedback from medical professionals.", "elementsJson": [ "headline_text", "subtitle_text", "bullet_list", "quote_block", "footnote" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/92", "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173", "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-92", "components": [ { "bbox": null, "kind": "callout", "text": "KOL's provided other reasons for explants beyond device failure and lack of efficacy, such as “intolerable” patient discomfort, “untenable” recharging requirements, adverse effects, and improper indications.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd953-3f3d-76db-b33e-20914d4c7d7c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.88, "x": 0.06, "y": 0.18 }, "kind": "paragraph", "text": "KOL's provided other reasons for explants beyond device failure and lack of efficacy, such as “intolerable” patient discomfort, “untenable” recharging requirements, adverse effects, and improper indications.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "7753cd77-f996-4f4a-bef5-c6d97f76678e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.12, "w": 0.83, "x": 0.11, "y": 0.44 }, "kind": "quote", "text": "I've explanted a lot of Nevro because of lot of my colleagues started implanting it for indications I didn't agree with. You need some form of neuropathic pain like a previous surgery or trauma. It won't work for regular back pain like if it's your joints or a disc.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "92df2316-89e4-461d-a60c-af0bf39f2807", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.83, "x": 0.11, "y": 0.27 }, "kind": "quote", "text": "Senza had a very high explant rate because of patient discomfort. The frequency of recharging was untenable. Some patients got sore skin from the charging coil. Having to do it every day could make the skin sore. It became intolerable to some patients. I have a friend who explanted 3 Nevro devices in one day. He's not a big Nevro guy anymore.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b2865355-ff08-4ae0-9eca-f169b9327e8b", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "“Senza had a very high explant rate because of patient discomfort. The frequency of recharging was untenable. Some patients got sore skin from the charging coil. Having to do it every day could make the skin sore. It became intolerable to some patients. I have a friend who explanted 3 Nevro devices in one day. He’s not a big Nevro guy anymore.” —KOL; “I’ve explanted a lot of Nevro because of lot of my colleagues started implanting it for indications I didn’t agree with. You need some form of neuropathic pain like a previous surgery or trauma. It won’t work for regular back pain like if it’s your joints or a disc.” —KOL", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd953-3f3d-76db-b33e-262a819dd003", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.2, "x": 0.06, "y": 0.94 }, "kind": "source-note", "text": "Source: Consultation calls with experts", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "3cb2e067-a30e-4205-8463-34c2df91440b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.45, "x": 0.06, "y": 0.09 }, "kind": "title", "text": "6. A covered-up device failure and explants crisis\nThe 33% explant rate (cont'd)", "attrs": null, "subkind": "action-title", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b45d6889-ba3a-4990-83a0-5e9be7aff0fb", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.45, "x": 0.06, "y": 0.04 }, "kind": "title", "text": "Scorpion Capital | Nevro (NYSE: NVRO)", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "a9ef13d2-1efb-4d7d-a181-ee9e136fcb22", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [ { "name": "authority-citation", "slug": null, "matchId": "e0c87612-2ce2-43ab-a254-7159026176af", "evidence": "Uses KOL quotes to validate the claim of high explant rates.", "confidence": 0.9 } ], "arcBeats": [ { "to": 150, "from": 51, "beatId": "903c076a-f368-4ca1-844c-277874c1afb2", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Victory", "beatSlug": "overcoming-monster-the-victory", "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }